Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-effect relationship of ropivacaine + dexmedetomidine for labor analgesia
ChiCTR2200059557Phase 4Recruiting
- Sponsor
- Linping District Women and Children Care Hospital
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine and dexmedetomidine in labor pain (4 arms), sponsored by Linping District Women and Children Care Hospital. Primary endpoints: Success rate of labor analgesia, PH of umbilical artery blood and 1 more. Started Jun 2022; status: recruiting.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2200059557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059557.